Alcolase
Copenhagen, DK · 6 known investors
Alcolase is developing a liposomal enzyme supplement that delivers three enzymes to the stomach to break down alcohol and acetaldehyde before absorption into the bloodstream, aimed at people with ALDH2 deficiency and alcohol intolerance. The company targets consumers affected by alcohol intolerance, with initial markets in Singapore and South Korea.
BiotechConsumerWellness & Fitness
Investors · 6
.jpeg){kind=logo}
Ada VenturesLondon · $317.5K – $1.3M
AntlerSingapore · $3M – $10M
Antler AustraliaSydney · $3M – $10M
Elmehøj VenturesCopenhagenvia Allan Rasmussen · inferred
Delphinus Venture Capitalreported · 2 sources
Also in the syndicate · 1
Manigoff Investlead
Funding
SEC filings, press & company announcements- Undisclosed amountSeed RoundMay 2026
Ada Ventures (lead), Antler (lead), Delphinus Venture Capital (lead), Manigoff Invest (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Alcolase do?
- Alcolase is developing a liposomal enzyme supplement that delivers three enzymes to the stomach to break down alcohol and acetaldehyde before absorption into the bloodstream, aimed at people with ALDH2 deficiency and alcohol intolerance. The company targets consumers affected by alcohol intolerance, with initial markets in Singapore and South Korea.
- Who are Alcolase's investors?
- Alcolase's investors include Ada Ventures, Antler, Antler Australia, Elmehøj Ventures, Delphinus Venture Capital.
- Where is Alcolase headquartered?
- Alcolase is headquartered in Copenhagen, DK.